TMO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Thermo Fisher Scientific Inc (TMO) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst ratings, and potential for long-term growth outweigh the short-term insider selling activity and minor pre-market price decline.
The MACD is positively expanding (4.592), indicating bullish momentum. RSI is neutral at 64.612, and moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R1: 503.288), suggesting potential upward movement.
Strong financial performance in Q4 2025, with revenue, net income, and EPS all showing growth.
Positive analyst sentiment, including a recent 'Buy' rating from Citi with a $685 price target and an 'Outperform' rating from Evercore ISI.
The company's Clario acquisition and Pharma 4.0 transformation initiatives are expected to drive long-term growth.
Insider selling has increased significantly (3567.45%) over the last month.
The stock has a short-term probability of slight declines (-0.22% next day, -1.13% next week).
Gross margin dropped by -3.07% YoY in Q4 2025.
In Q4 2025, revenue increased by 7.20% YoY to $12.22 billion, net income rose by 7.32% YoY to $1.96 billion, and EPS grew by 8.79% YoY to $5.2. However, gross margin declined by -3.07% YoY to 41.02%.
Analysts maintain a positive outlook on TMO. Citi has a $685 price target and a Buy rating, while Evercore ISI has an Outperform rating with a $575 price target. DZ Bank initiated coverage with a Buy rating and a $610 price target. Other analysts have also raised price targets, reflecting confidence in the company's growth potential.
